$VSTM News Article - Verastem Oncology Announces Dosing of First Patient in Yakult Honsha Co., Ltd.'s Japanese Bridging Study Evaluating COPIKTRA (Duvelisib) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
https://marketwirenews.com/news-releases/vera...46237.html